Search Results - "Stange, Eduard"

Refine Results
  1. 1

    An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease by Wehkamp, Jan, Stange, Eduard F

    Published in Frontiers in immunology (15-04-2020)
    “…The Paneth cells reside in the small intestine at the bottom of the crypts of Lieberkühn, intermingled with stem cells, and provide a niche for their neighbors…”
    Get full text
    Journal Article
  2. 2

    Intestinal barrier in inflammatory bowel disease by Antoni, Lena, Nuding, Sabine, Wehkamp, Jan, Stange, Eduard F

    Published in World journal of gastroenterology : WJG (07-02-2014)
    “…A complex mucosal barrier protects as the first line of defense the surface of the healthy intestinal tract from adhesion and invasion by luminal…”
    Get full text
    Journal Article
  3. 3

    Microbiota and mucosal defense in IBD: an update by Stange, Eduard F, Schroeder, Bjoern O

    “…: Inflammatory bowel diseases (IBD) are on the rise worldwide. This review covers the current concepts of the etiology of Crohn´s disease and ulcerative…”
    Get more information
    Journal Article
  4. 4

    Twenty‐five years of biologicals in IBD: What´s all the hype about? by Herrlinger, Klaus R., Stange, Eduard F.

    Published in Journal of internal medicine (01-10-2021)
    “…Twenty‐five years ago the field was revolutionized by the introduction of infliximab as the first hybrid anti‐TNF‐antibody. Subsequently, other humanized…”
    Get full text
    Journal Article
  5. 5

    Dysbiosis in inflammatory bowel diseases: egg, not chicken by Stange, Eduard F

    Published in Frontiers in medicine (23-05-2024)
    “…There is agreement that inflammatory bowel diseases are, both in terms of species composition and function, associated with an altered intestinal microbiome…”
    Get full text
    Journal Article
  6. 6

    Inflammatory Bowel Disease by Wehkamp, Jan, Götz, Martin, Herrlinger, Klaus, Steurer, Wolfgang, Stange, Eduard F

    Published in Deutsches Ärzteblatt international (05-02-2016)
    “…Inflammatory bowel diseases are common in Europe, with prevalences as high as 1 in 198 persons (ulcerative colitis) and 1 in 310 persons (Crohn's disease)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficile by Nuding, Sabine, Frasch, Tina, Schaller, Martin, Stange, Eduard F, Zabel, Lutz T

    Published in Antimicrobial agents and chemotherapy (01-10-2014)
    “…Accelerating rates of health care-associated infections caused by Clostridium difficile, with increasing recurrence and rising antibiotic resistance rates,…”
    Get full text
    Journal Article
  9. 9

    Inflammatory bowel disease: an impaired barrier disease by Jäger, Simon, Stange, Eduard F., Wehkamp, Jan

    Published in Langenbeck's archives of surgery (01-01-2013)
    “…Background The intestinal barrier is a delicate structure composed of a single layer of epithelial cells, the mucus, commensal bacteria, immune cells, and…”
    Get full text
    Journal Article
  10. 10

    Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1 by Schroeder, Bjoern O., Wu, Zhihong, Nuding, Sabine, Groscurth, Sandra, Marcinowski, Moritz, Beisner, Julia, Buchner, Johannes, Schaller, Martin, Stange, Eduard F., Wehkamp, Jan

    Published in Nature (London) (20-01-2011)
    “…Human β-defensin 1 shows its true colours Defensins are key effector molecules of innate immunity, protecting the host from infectious microbes and shaping the…”
    Get full text
    Journal Article
  11. 11

    Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense by Teltschik, Zora, Wiest, Reiner, Beisner, Julia, Nuding, Sabine, Hofmann, Claudia, Schoelmerich, Juergen, Bevins, Charles L., Stange, Eduard F., Wehkamp, Jan

    Published in Hepatology (Baltimore, Md.) (01-04-2012)
    “…Liver cirrhosis is associated with bacterial translocation (BT) and endotoxemia. Most translocating bacteria belong to the common intestinal microbiota,…”
    Get full text
    Journal Article
  12. 12

    Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo by Becker, Svetlana, Oelschlaeger, Tobias A, Wullaert, Andy, Vlantis, Katerina, Pasparakis, Manolis, Wehkamp, Jan, Stange, Eduard F, Gersemann, Michael

    Published in PloS one (13-02-2013)
    “…The human colon harbours a plethora of bacteria known to broadly impact on mucosal metabolism and function and thought to be involved in inflammatory bowel…”
    Get full text
    Journal Article
  13. 13

    Paneth's disease by Wehkamp, Jan, Stange, Eduard F.

    Published in Journal of Crohn's and colitis (01-11-2010)
    “…A correction notice has been published, see: https://doi.org/10.1093/ecco-jcc/jjac104 In about 70% of patients Crohn's disease (CD) affects the small…”
    Get full text
    Journal Article
  14. 14

    Improvement of a 'Leaky' Intestinal Barrier by Stange, Eduard F

    Published in Digestive diseases (Basel) (01-01-2017)
    “…In Crohn's disease, the mucus layer appears to be defective in terms of low defensin levels and lack of antibacterial activity. These deficiencies actually…”
    Get more information
    Journal Article
  15. 15

    Recent advances and emerging therapies in the non-surgical management of ulcerative colitis [version 1; peer review: 3 approved] by Wehkamp, Jan, Stange, Eduard F

    Published in F1000 research (2018)
    “…The so-called "biologicals" (monoclonal antibodies to various inflammatory targets like tumor necrosis factor or integrins) have revolutionized the treatment…”
    Get full text
    Journal Article
  16. 16

    Extraintestinal manifestations and complications in inflammatory bowel diseases by Rothfuss, Katja S, Stange, Eduard F, Herrlinger, Klaus R

    Published in World journal of gastroenterology : WJG (14-08-2006)
    “…Crohn’s disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases (IBD) that often involve organs other than those of the…”
    Get full text
    Journal Article
  17. 17

    Induction of Human β-Defensin 2 by the Probiotic Escherichia coli Nissle 1917 Is Mediated through Flagellin by Schlee, Miriam, Wehkamp, Jan, Altenhoefer, Artur, Oelschlaeger, Tobias A, Stange, Eduard F, Fellermann, Klaus

    Published in Infection and Immunity (01-05-2007)
    “…Human β-defensin 2 (hBD-2) is an inducible antimicrobial peptide synthesized by the epithelium to counteract bacterial adherence and invasion. Proinflammatory…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis by Koeninger, Louis, Armbruster, Nicole S, Brinch, Karoline Sidelmann, Kjaerulf, Søren, Andersen, Birgitte, Langnau, Carolin, Autenrieth, Stella E, Schneidawind, Dominik, Stange, Eduard F, Malek, Nisar P, Nordkild, Peter, Jensen, Benjamin A H, Wehkamp, Jan

    Published in Frontiers in immunology (31-01-2020)
    “…Defensins represents an integral part of the innate immune system serving to ward off potential pathogens and to protect the intestinal barrier from microbial…”
    Get full text
    Journal Article
  20. 20

    Crohn’s disease-derived monocytes fail to induce Paneth cell defensins by Courth, Lioba F., Ostaff, Maureen J., Mailänder-Sánchez, Daniela, Malek, Nisar P., Stange, Eduard F., Wehkamp, Jan

    “…Crohn’s disease (CD) is associated with a multitude of genetic defects, many of which likely affect Paneth cell function. Paneth cells reside in the small…”
    Get full text
    Journal Article